Novartis Newswire

Novartis Newswire

Comprehensive Real-Time News Feed for Novartis.

Results 1 - 20 of 1,505 in Novartis

  1. 1,596 Shares in Novartis AG (NVS) Acquired by Massey Quick & Co. LLCRead the original story w/Photo

    2 hrs ago | IntersportsWire

    Massey Quick & Co. LLC acquired a new position in Novartis AG during the first quarter, according to its most recent 13F filing with the SEC.

    Comment?

  2. Gluskin Sheff & Assoc Inc. Has $13.27 Million Position in Novartis AGRead the original story w/Photo

    14 hrs ago | IntersportsWire

    Gluskin Sheff & Assoc Inc. lowered its stake in shares of Novartis AG by 10.6% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 126,170 shares of the company's stock after selling 14,900 shares during the period.

    Comment?

  3. North Star Investment Management Corp. Has $129,000 Stake in Novartis AGRead the original story w/Photo

    21 hrs ago | Daily Political

    North Star Investment Management Corp. boosted its stake in Novartis AG by 1.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The fund owned 1,542 shares of the company's stock after buying an additional 16 shares during the period.

    Comment?

  4. Jones Financial Companies Lllp Has $6.88 Million Stake in Novartis AGRead the original story w/Photo

    Yesterday | IntersportsWire

    Jones Financial Companies Lllp increased its stake in Novartis AG by 10.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 92,569 shares of the company's stock after buying an additional 8,669 shares during the period.

    Comment?

  5. Novartis AG (NVS) Earns Daily News Impact Score of 0.23Read the original story w/Photo

    Yesterday | IntersportsWire

    Media headlines about Novartis AG have trended somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive news coverage by monitoring more than twenty million news and blog sources in real time.

    Comment?

  6. Novartis Ag's (NVS) "Neutral" Rating Reiterated at J P Morgan Chase & CoRead the original story w/Photo

    Yesterday | IntersportsWire

    ... research analysts also recently issued reports about the company. UBS AG reiterated a "neutral" rating on shares of Novartis AG in a research note on Wednesday, May 24th. Cowen and Company downgraded Novartis AG from an "outperform" rating to a ...

    Comment?

  7. FY2017 Earnings Estimate for Novartis AG Issued By Jefferies GroupRead the original story w/Photo

    Saturday | IntersportsWire

    Jefferies Group decreased their FY2017 earnings per share estimates for shares of Novartis AG in a research report issued to clients and investors on Thursday. Jefferies Group analyst J. Holford now anticipates that the company will earn $4.70 per share for the year, down from their prior forecast of $4.74.

    Comment?

  8. Novartis AG (NYSE:NVS) Upgraded at Barclays PLCRead the original story w/Photo

    Friday | IntersportsWire

    NVS has been the topic of a number of other research reports. Vetr upgraded Novartis AG from a buy rating to a strong-buy rating and set a $85.25 price target on the stock in a research note on Wednesday, March 8th.

    Comment?

  9. Novartis AG's (NYSE:NVS) "Market Perform" Rating Reiterated at Leerink SwannRead the original story w/Photo

    Friday Jul 21 | IntersportsWire

    ... of other equities analysts also recently commented on the stock. Zacks Investment Research upgraded shares of Novartis AG from a strong sell rating to a hold rating in a research note on Monday, May 1st. Vetr upgraded shares of Novartis AG from a ...

    Comment?

  10. New England Asset Management Inc. Lowers Position in Novartis AGRead the original story w/Photo

    Friday Jul 21 | Daily Political

    New England Asset Management Inc. lowered its stake in shares of Novartis AG by 36.6% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,250 shares of the company's stock after selling 1,300 shares during the period.

    Comment?

  11. GlaxoSmithKline PLC (NYSE:GSK) Stock Rating Lowered by Zacks Investment ResearchRead the original story w/Photo

    Friday Jul 21 | AmericanBankingNews.com

    ... on Glaxo's efforts to develop its pipeline as well. Performance of new products as well as of those acquired from Novartis has been encouraging. However, persistent challenges like stiff competition, genericization and pricing pressure along with ...

    Comment?

  12. Comerica Securities Inc. Acquires 1,338 Shares of Novartis AGRead the original story w/Photo

    Thursday Jul 20 | IntersportsWire

    Comerica Securities Inc. raised its position in Novartis AG by 17.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,908 shares of the company's stock after buying an additional 1,338 shares during the period.

    Comment?

  13. Novartis AG (NVS) Lowered to "Underperform" at Credit Suisse GroupRead the original story w/Photo

    Thursday Jul 20 | IntersportsWire

    ... about the company. Leerink Swann reaffirmed a "market perform" rating and issued a $83.00 target price on shares of Novartis AG in a research report on Thursday, June 22nd. J P Morgan Chase & Co reissued a "neutral" rating on shares of Novartis AG ...

    Comment?

  14. Research Analysts Set Expectations for Novartis AG's FY2020 EarningsRead the original story w/Photo

    Thursday Jul 20 | AmericanBankingNews.com

    Analysts at Leerink Swann boosted their FY2020 earnings per share estimates for shares of Novartis AG in a research note issued to investors on Tuesday. Leerink Swann analyst S. Fernandez now expects that the company will post earnings per share of $5.79 for the year, up from their prior forecast of $5.69.

    Comment?

  15. Novartis Ag's (NVS) Neutral Rating Reiterated at J P Morgan Chase & CoRead the original story w/Photo

    Thursday Jul 20 | Daily Political

    Other equities research analysts have also recently issued research reports about the company. Vetr cut Novartis AG from a buy rating to a hold rating and set a $78.32 target price on the stock.

    Comment?

  16. Looking For Value In The Deal Sweet SpotRead the original story w/Photo

    Thursday Jul 20 | Seeking Alpha

    ... in CAR-T therapy, which has generated much excitement but still has safety questions hanging over it. Of course, Novartis already has a presence here so is unlikely to be interested, but Juno could entice one of its rivals. Meanwhile, a takeover ...

    Comment?

  17. Mission Wealth Management LLC Has $983,000 Position in Novartis AGRead the original story w/Photo

    Thursday Jul 20 | IntersportsWire

    Mission Wealth Management LLC lowered its stake in shares of Novartis AG by 11.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 13,239 shares of the company's stock after selling 1,642 shares during the period.

    Comment?

  18. Oppenheimer Asset Management Inc. Purchases Shares of 245,682 Novartis AGRead the original story w/Photo

    Thursday Jul 20 | Daily Political

    Oppenheimer Asset Management Inc. purchased a new position in Novartis AG during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 245,682 shares of the company's stock, valued at approximately $18,246,000.

    Comment?

  19. Global Financial Private Capital LLC Takes Position in Novartis AGRead the original story w/Photo

    Wednesday Jul 19 | IntersportsWire

    Global Financial Private Capital LLC purchased a new stake in Novartis AG during the first quarter, according to its most recent filing with the Securities and Exchange Commission . The fund purchased 232,685 shares of the company's stock, valued at approximately $17,282,000.

    Comment?

  20. Novartis Will Hit $100 This YearRead the original story w/Photo

    Wednesday Jul 19 | Seeking Alpha

    ... segment. Management is remaining tight lipped about a sale or spin-off. There are a lot of moving parts going on in Novartis AG (ADR)(NYSE: NVS ) at present, but I still see strong growth coming down the track. The company announced its second ...

    Comment?